Working Life: Nawal Ouzren, CEO of Sensorion
August 13, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, Sensorion, Working Life, feature, pharma
Pharmafocus caught up with Sensorion CEO Nawal Ouzren to take a look at her path throughout her career and get …
Indicted GOP congressman Chris Collins’ terminates re-election campaign
August 13, 2018Medical Communications, Sales and Marketing Chris Collins, Innate Therapeutics, US, pharma
Indicted republican congressman Chris Collins has performed a U-turn since his arrest on Wednesday under allegations of insider trading, confirming …
Astellas acquires gene therapy group Quethera in £85 million deal
August 13, 2018Sales and Marketing Astellas, Japan, gene therapy, ocular, quethera, vision
The Japanese company Astellas Pharma has acquired British gene therapy group Quethera in a deal worth up to £85 million. …
FDA approves RNA therapy for rare genetic disease
August 13, 2018Sales and Marketing FDA, Onpattro, Orphan Drugs, RNA, rare diseases
The US Food and Drug Administration has approved the RNA-based therapy Onpattro, for the treatment of the rare genetic disease …
Chicago Judge overturns $140 million AbbVie AndroGel verdict
August 13, 2018Sales and Marketing AbbVie, Litigation, androgel, legal, testosterone
A US Judge has overturned a $140.1 million verdict against the New York-listed AbbVie Inc. The verdict, which ruled in …
FDA approves first oral therapy for rare Fabry disease
August 13, 2018Sales and Marketing FDA, Fabry disease, US, pharma
Amicus has revealed that its therapy Galafold (migalastat) has been awarded approval by the FDA in the treatment of adult …
NHS scraps restriction on availability of J&J’s Imbruvica in leukaemia patients
August 10, 2018Medical Communications, Sales and Marketing Cancer, J&J, JJ, Johnson & Johnson, NHS, NICE, UK, imbruvica, leukaemia, pharma
The NHS has dropped a controversial restriction preventing leukaemia patients from accessing Johnson & Johnson’s tyrosine kinase inhibitor Imbruvica (ibrutinib), …
Top Ten most popular articles on Pharmafile.com this week
August 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ADHD, Allergan, MHRA, UK, brexit, iraq, pharma, top 10
There was some clarity on Brexit this week as the MHRA set out a plan for the implantation period set …
Letters to doctors reduce opioid prescriptions, study shows
August 10, 2018Medical Communications OxyContin, USA, fentanyl, opioid, opioid crisis, research, study
A study has shown that Doctors who received a letter from the medical examiner’s office informing them of their patient’s …
FDA approved more generics in July than any previous month
August 10, 2018Medical Communications FDA, generics, pharma
FDA Commissioner Scott Gottlieb took to Twitter to announce the news that the FDA smashed its previous record for number …
ABPI Chief warns of Brexit impact on EU
August 10, 2018Medical Communications ABPI, EU, UK, brexit, trade lobby
The head of the Association of the British Pharmaceutical Industry (ABPI) has warned that European governments have failed to recognise …
US Congressman arrested over insider trading in biopharma firm
August 9, 2018Research and Development, Sales and Marketing Chris Collins, Innate, Innate Immunotherapeutics, US, congress, multiple sclerosis, pharma
A Republican Congressman has been arrested by the FBI over on charges of insider trading with shares in Australian biopharmaceutical …
FDA expands list of valsartan recalls
August 9, 2018Medical Communications China, FDA, US, heart medication, recall, valsartan
The US Food and Drug Administration (FDA) has expanded a list of products containing valsartan that are to be recalled. …
NICE recommends Eli Lilly’s psoriatic arthritis drug
August 9, 2018Research and Development, Sales and Marketing Eli Lilly, England, NICE, Wales, psoriatic arthritis
Eli Lilly have announced that the monoclonal antibody ixekizumab, has been recommended by NICE for use as a treatment option …
NICE recommends Pfizer’s Besponsa in rare leukaemia following review
August 9, 2018Sales and Marketing NICE, Pfizer, leukaemia, pharma
Pfizer has revealed that NICE has finally decided to recommend its CD22-targeting monoclonal antibody Besponsa (inotuzumab ozogamicin) in the treatment …
Insys Therapeutics reaches $150m agreement to settle opioid marketing case
August 9, 2018Medical Communications, Sales and Marketing Litigation, Subsys, US Department of Justice, fentanyl, insys, opioid, pharma
The Arizona-based pharma company Insys Therapeutics has reached an agreement to pay $150 million to the US Department of Justice …
AstraZeneca to pay $110m to settle allegations of fraudulent marketing in Texas
August 8, 2018Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Texaas, US, pharma
AstraZeneca has backed down in a dispute with the State of Texas over allegations it had defrauded the state’s Medicaid …
Stem cells could ‘reset’ immune system in Crohn’s disease patients
August 8, 2018Research and Development Crohn’s disease, Stem cells, crohn's disease, trials
A clinical trial led by researchers at Queen Mary University, London is looking into ways in which patients with Crohn’s …
MSD’s experimental vaccine to be used in fight against Congo Ebola outbreak
August 8, 2018Research and Development Congo, Ebola, MSD, Merck, Vaccine, pharma
MSD’s experimental drug rVSV-ZEBOV will be used in tackling the latest Ebola outbreak in the Democratic Republic of Congo, after …
Strong efficacy but serious side-effects with Spark’s haemophilia drug drop shares by 30%
August 8, 2018Research and Development Spark Therapeutics, haemophilia, pharma
Spark Therapeutics has been left reeling after it revealed new data on its haemophilia A treatment, which, while promising in …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
